SIGN UP

Joseph Kim (Andrew Harnik/AP Images)

May 11, 2022 06:48 AM EDT

Inovio's longtime CEO is out as Covid vaccine laggard throws in the towel on PhIII, pivots to booster

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Early bits of in vivo CAR-T human data emerge from biotech trials in China

Bristol Myers to lay off over 500 workers in New Jersey

PTC's Huntington’s study succeeds, but accelerated approval uncertain

Recursion cuts nearly half of its pipeline, including its most advanced program

J&J's eye disease gene therapy bota-vec fails in Phase 3 trial

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges